A photo of Gary Lewis McPhail.

Clinical Medical Director, Pulmonary Ambulatory Services, Division of Pulmonary Medicine

Associate Director, Cystic Fibrosis Research TDC Site, Division of Pulmonary Medicine

Professor, UC Department of Pediatrics

513-636-6771

513-636-4615

Board Certified

My Biography & Research

Clinical Interests

Medical education; outcomes research; quality improvement; sleep medicine; thoracic insufficiency syndrome

Research Interests

Medical education; pulmonary vascular disease; thoracic insufficiency syndrome

Academic Affiliation

Professor, UC Department of Pediatrics

Departments

Pulmonary Medicine, Rare Lung Diseases, Sleep Disorders, Home Ventilator, Cystic Fibrosis, Pulmonary Medicine

My Locations

My Education

MD: University of Texas Southwestern Medical Center, Dallas TX, 2001.

Residency: Children's Medical Center, University of Texas Southwestern, Dallas, TX, 2004.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2007.

Certification: Pediatrics, 2004; Pediatric Pulmonary, 2008.

My Publications

Improving Detection of Rapid Cystic Fibrosis Disease Progression-Early Translation of a Predictive Algorithm Into a Point-of-Care Tool. Szczesniak, RD; Brokamp, C; Su, W; Mcphail, GL; Pestian, J; Clancy, JP. IEEE Journal of Translational Engineering in Health and Medicine-JTEHM. 2019; 7:2800108-8.

Use and Incidence of Adverse Effects of Proton Pump Inhibitors in Patients with Cystic Fibrosis. McCrory, BE; Harper, HN; McPhail, GL. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2018; 38:725-729.

Early Detection of Rapid Cystic Fibrosis Disease Progression Tailored to Point of Care: A Proof-of-Principle Study. Szczesniak, R; Brokamp, C; Su, W; McPhail, GL; Pestian, J; Clancy, JP; IEEE, . 2017; 2017-December:204-207.

Protocol of a Pilot Study of Technology-Enabled Coproduction in Pediatric Chronic Illness Care. Kaplan, HC; Thakkar, SN; Burns, L; Chini, B; Dykes, DM; McPhail, GL; Moore, E; Saeed, SA; Eslick, I; Margolis, PA; et al. JMIR Research Protocols. 2017; 6:e71-e71.

Constrictive Bronchiolitis in Cystic Fibrosis Adolescents with Refractory Pulmonary Decline. Harris, WT; Boyd, JT; McPhail, GL; Brody, AS; Szczesniak, RD; Korbee, LL; Baker, ML; Clancy, JP. Annals of the American Thoracic Society. 2016; 13:2174-2183.

Adolescents' Spirituality and Cystic Fibrosis Airway Clearance Treatment Adherence: Examining Mediators. Grossoehme, DH; Szczesniak, RD; Mrug, S; Dimitriou, SM; Marshall, A; McPhail, GL. Journal of Pediatric Psychology. 2016; 41:1022-1032.

Decision Making for Children with Obstructive Sleep Apnea without Tonsillar Hypertrophy. Ishman, SL; Tang, A; Cohen, AP; Babiker, HE; Chini, B; Ehsan, Z; Fleck, RJ; Gordon, C; McPhail, GL; Pan, B; et al. Otolaryngology - Head and Neck Surgery. 2016; 154:527-531.

Predicting Future Lung Function Decline in Cystic Fibrosis Patients: Statistical Methods and Clinical Connections. Szczesniak, RD; Mcphail, GL; Li, D; Amin, RS; Clancy, JP. Pediatric Pulmonology. 2016; 51:217-218.

Lumacaftor alone and combined with ivacaftor: preclinical and clinical trial experience of F508del CFTR correction. Brewington, JJ; McPhail, GL; Clancy, JP. Expert Review of Respiratory Medicine. 2016; 10:5-17.

Concentration of fractional excretion of nitric oxide (FENO): A potential airway biomarker of restored CFTR function. Kotha, K; Szczesniak, RD; Naren, AP; Fenchel, MC; Duan, LL; McPhail, GL; Clancy, JP. Journal of Cystic Fibrosis. 2015; 14:733-740.